Literature DB >> 14512208

Antidepressant effects of light therapy combined with sleep deprivation are influenced by a functional polymorphism within the promoter of the serotonin transporter gene.

Francesco Benedetti1, Cristina Colombo, Alessandro Serretti, Cristina Lorenzi, Adriana Pontiggia, Barbara Barbini, Enrico Smeraldi.   

Abstract

BACKGROUND: A functional polymorphism within the promoter of the serotonin transporter has been shown to influence the antidepressant response to serotonergic drug treatments and to total sleep deprivation (TSD). The short-term relapse that follows acute response to TSD has been successfully prevented by combining TSD with light therapy. The mechanism of action of this combined treatment is unknown.
METHODS: We tested the hypothesis that allelic variation of the serotonin transporter (5-HTT) linked polymorphic region (5-HTTLPR) could influence the response to the combination of light therapy and TSD. Twenty-two bipolar depressed inpatients were administered a night of TSD combined with 30 min light therapy given during the TSD night and in the morning after recovery sleep. 5-HTTLPR was genotyped using polymerase chain reaction techniques. Changes in perceived mood were rated on a visual analog scale.
RESULTS: Light therapy sustained the effect of TSD. The effect was more marked in homozygotes for the long variant of 5-HTTLPR than in heterozygotes and homozygotes for the short variant.
CONCLUSIONS: The influence of 5-HTTLPR on response to the combination of TSD and light therapy is similar to that observed on response to TSD and serotonergic drug treatments.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14512208     DOI: 10.1016/s0006-3223(02)01894-2

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  12 in total

Review 1.  Bright light therapy for depression: a review of its effects on chronobiology and the autonomic nervous system.

Authors:  Mark A Oldham; Domenic A Ciraulo
Journal:  Chronobiol Int       Date:  2014-01-07       Impact factor: 2.877

2.  Sleep disturbance in euthymic bipolar patients.

Authors:  Louisa G Sylvia; Jamie M Dupuy; Michael J Ostacher; Colleen M Cowperthwait; Aleena C Hay; Gary S Sachs; Andrew A Nierenberg; Roy H Perlis
Journal:  J Psychopharmacol       Date:  2011-09-29       Impact factor: 4.153

3.  Chronic modulation of serotonergic neurotransmission with sertraline attenuates the loudness dependence of the auditory evoked potential in healthy participants.

Authors:  Julian G Simmons; Pradeep J Nathan; Gregor Berger; Nicholas B Allen
Journal:  Psychopharmacology (Berl)       Date:  2011-04-05       Impact factor: 4.530

Review 4.  Biological rhythms, higher brain function, and behavior: Gaps, opportunities, and challenges.

Authors:  Ruth Benca; Marilyn J Duncan; Ellen Frank; Colleen McClung; Randy J Nelson; Aleksandra Vicentic
Journal:  Brain Res Rev       Date:  2009-09-18

Review 5.  Human biomarkers of rapid antidepressant effects.

Authors:  Carlos A Zarate; Daniel C Mathews; Maura L Furey
Journal:  Biol Psychiatry       Date:  2013-01-29       Impact factor: 13.382

Review 6.  Neuronal correlates of depression.

Authors:  Dipesh Chaudhury; He Liu; Ming-Hu Han
Journal:  Cell Mol Life Sci       Date:  2015-11-05       Impact factor: 9.261

Review 7.  Update of sleep alterations in depression.

Authors:  Andrés Barrera Medina; DeboraYoaly Arana Lechuga; Oscar Sánchez Escandón; Javier Velázquez Moctezuma
Journal:  Sleep Sci       Date:  2014-09-27

Review 8.  Light therapy for non-seasonal depression: systematic review and meta-analysis.

Authors:  Stefan Perera; Rebecca Eisen; Meha Bhatt; Neera Bhatnagar; Russell de Souza; Lehana Thabane; Zainab Samaan
Journal:  BJPsych Open       Date:  2016-03-04

Review 9.  Antidepressant chronotherapeutics for bipolar depression.

Authors:  Francesco Benedetti
Journal:  Dialogues Clin Neurosci       Date:  2012-12       Impact factor: 5.986

Review 10.  Role of Chronobiology as a Transdisciplinary Field of Research: Its Applications in Treating Mood Disorders.

Authors:  Okan Çalıyurt
Journal:  Balkan Med J       Date:  2017-10-26       Impact factor: 2.021

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.